Pharma Leaders

JUNE 8, 2023

Under PDUFA VII, the agency agreed to create the program by December 2022 and then to report aggregate data on an annual basis starting June 30, 2024, including data sources, study designs and the types of regulatory requests.

FDA 40

FDA Prescription Education Medical 40

Clarivate

AUGUST 7, 2024

The three largest pharmacy benefit managers (PBMs) in the United States—Express Scripts, OptumRx and CVS Caremark—control more than 80% of the market share (per Clarivate data, as of January 2024). This market dominance, coupled with other concerns, particularly around pricing opacity, has made PBMs a target of regulators and politicians.

Retail 59

Retail Marketing Competition Biopharma 59

Pharmaceutical Representative Training

JUNE 22, 2024

Pharmaceutical representatives (pharma reps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

PM360

MAY 21, 2024

The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF. It all starts with reaching HCPs and pharmacists across POC platforms with program information at the points of prescription and dispensing.

Electronics 52

Electronics Prescription Pharmaceutical manufacturing Patients 52

PM360

SEPTEMBER 30, 2024

In this issue, we take a closer look at the patient experience and how it is constantly evolving in the pharma industry. This integration allows patients to book appointments, access their medication history, and manage prescriptions all in one place, simplifying their experience.

Patients 59

Patients Education Doctors Pharmaceutical 59

pharmaphorum

JANUARY 24, 2023

Pharma will be focusing more on relevant research, support, and a better mix of non-promotional and promotional interaction. Given the funding environment for innovative medicines that is faced by all pharma, large or small, once assets are approved, however, this 2023 reset seems a necessary response.

Medicine 91

Medicine Healthcare Healthcare Pharma 91

PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. The price is available to cash-paying patients with a valid prescription. Currently, an estimated 37.3 of the U.S.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

Clarivate

SEPTEMBER 5, 2024

This blog summarizes a portion of the data collected, which was previously shared in a poster presented at the May 2024 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Conference (Read the poster ). Nearly early 1 in 5 expect to withdraw some Medicare Advantage plans from the market due to the law (see figure 4).

Insurance 52

Insurance Marketing Manufacturing Prescription 52

Eversana Intouch

MARCH 19, 2024

That’s why in 2024, we find ourselves still failing women in healthcare. They are more likely than men to suffer chronic conditions and use prescription drugs across all age groups. When it comes to healthcare, however, this model often fails to consider the good of all. Women represent more of the health care system than men.

Healthcare 59

Healthcare Healthcare Marketing Prescription 59

pharmaphorum

OCTOBER 3, 2022

The third ALS treatment to be given FDA approval, following Mitsubishi Tanabe’s Radicava ($170,000 per year) and generic drug riluzole – Relyvrio is priced at around $12,500 per 28-day prescription. Clearer’ data isn’t expected until 2024, with results from a late-stage phase 3 PHOENIX trial of around 600 patients due at that time.

Insurance 52

Insurance Prescription FDA Patients 52

PM360

APRIL 7, 2023

This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products. The 340B battle will rage on.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.

FDA 84

FDA Doctors Patients Prescription 84

PM360

SEPTEMBER 21, 2023

This product would be a more potent prescription version than the OTCs, Casberg notes. The product, manufactured by ARS Pharma and Neurelis Pharma, would be the first needle-free epinephrine alternative to autoinjectors, such as the EpiPen. In 2024, ARPA removes the 100% AMP cap.

Management 105

Management Manufacturing Sales Competition 105

Clarivate

DECEMBER 19, 2022

Insurers that incentivize using Walmart facilities in Medicare Advantage and prescription drug plans (PDPs) have seen success; Humana has a long-running standalone Part D plan with Walmart pharmacies as preferred network locations.

Competition 52

Competition Retail Insurance Marketing 52

PM360

AUGUST 7, 2024

Data on HCP engagement with pharma content—such as webinar attendance, whitepaper downloads, and digital tool use—along with message personalization can help develop strategies to better support HCPs in their roles as prescribers and educators. This can guide improvements in future educational materials.

Media 52

Media Education Physicians Marketing 52

PM360

DECEMBER 20, 2023

A significant battle for the hearts and minds of healthcare professionals (HCPs) will play out in social media during 2024. Fifty percent of responders said they changed prescriptions because of social media information. million self-identified HCPs on the platform to pharma marketers. Look for TikTok to merchandise the 4.7

Media 122

Media Physicians Pharma reps Pharma Rep 122

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. The entire pharma industry will be affected by the fallout.

Pharma 64

Pharma Pharmaceutical Manufacturing Marketing 64

Pharmaceutical Technology

JANUARY 16, 2023

Pharma may have to navigate a difficult path through relatively slow-to-fall inflation in regions outside the US. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines. The entire pharma industry will be affected by the fallout.

Pharma 52

Pharma Pharmaceutical Manufacturing Marketing 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024.

Marketing 104

Marketing Physicians Competition Patients 104

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

MARCH 30, 2022

Roughly 1 in 4 adults report difficulty affording their prescription drugs, according to KFF polling. in traditional categories like hospitals, prescription drugs and doctors, and clinical services through 2024, while pandemic-related effects like COVID vaccines, testing and treatment, and expanded Medicaid coverage fall off.

Pharma 189

Pharma Prescription Insurance Doctors 189

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. 31, 2024, and providers and payers are pushing for an extension.

Healthcare 52

Healthcare Healthcare Government Insurance 52

Pharmaceutical Technology

DECEMBER 2, 2022

After the mid-term election results, former President Donald Trump also announced his intention to run for re-election in the 2024 presidential election. If appointed to the role, Sanders will focus on universal healthcare and influencing the costs of prescription drugs.

Pharma 59

Pharma Government Healthcare Healthcare 59